NuVasive reports $282M in Q2 revenue — Up 8.5%

Written by Mackenzie Garrity | August 01, 2018 | Print  |

NuVasive released its second quarter 2018 financial results.

Here's what you need to know:

1. The company experienced an 8.5 percent increase in year-over-year revenues, topping $281.6 million.

2. NuVasive's second quarter income sits at $11.5 million,or $0.22 per share.

3. NuVasive reported a gross profit of $204.5 million for the second quarter.

4. For full-year 2018, the company expects to see revenues range between $1.095 billion and $1.105 billion, reflecting a 6.7 percent to 7.6 percent year-over-year increase.

5. NuVasive anticipates its diluted earnings per share to range between $2.37 and $2.40.

To view the full report, click here.

More articles on devices and implants:
Dr. Alexis Waguespack performs surgery with Mobi-C Cervical Disc: 3 insights
6 key players in the global thoracolumbar spine devices market
Spine Wave raises $5.3M in funding: 3 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months